Table of Contents 8 CVRx, Inc. (the "Company") was incorporated in Delaware and is headquartered in Minneapolis, Minnesota. The Company has developed and is marketing a medical device, Barostim, for heart failure ("HF") and resistant hypertension. The Company is focused on the sale of its product in the U.S. and Europe. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. G ...

CVRx, Inc. (NASDAQ:CVRX) Q2 2023 Earnings Conference Call July 25, 2023 5:30 PM ET Company Participants Mike Vallie – Senior Vice President-ICR Westwicke Nadim Yared – President and Chief Executive Officer Jared Oasheim – Chief Financial Officer Conference Call Participants Matthew O’Brien – Piper Sandler Margaret Kaczor – William Blair Bill Plovanic – Canaccord Genuity Alex Nowak – Craig-Hallum Frank Takkinen – Lake Street Capital Markets Operator Greetings, and welcome to the CVRx Q2 2023 Earnings Call. A ...

As of March 31, 2023 and December 31, 2022, our cash and cash equivalents were maintained with two financial institutions in the U.S., and our current deposits are likely in excess of insured limits. We believe these institutions have sufficient assets and liquidity to conduct their operations in the ordinary course of business with little or no credit risk to us. Evaluation of disclosure controls and procedures Changes in internal control over financial reporting 28 Item 1. Legal Proceedings Item 1A. Risk ...

CVRx, Inc. (NASDAQ:CVRX) Q1 2023 Earnings Conference Call April 27, 2023 5:00 PM ET Company Participants Michael Vallie - Investor Relations Nadim Yared - President and Chief Executive Officer Jared Oasheim - Chief Financial Officer Conference Call Participants Will Plovanic - Canaccord Genuity Alex Nowak - Craig-Hallum Capital Group Frank Takkinen - Lake Street Capital Markets Operator Greetings, and welcome to the CVRx Q1 2023 Earnings Call. At this time, all participants are in a listen-only-mode. A brie ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40545 CVRx, Inc. (Exact name of registrant as specified in its charter) Delaware 41-1983744 (State or other jurisdiction o ...

CVRx, Inc. (NASDAQ:CVRX) Q4 2022 Earnings Conference Call January 26, 2023 5:30 PM ET Company Participants Mike Vallie - Westwicke, ICR Company Nadim Yared - President and Chief Executive Officer Jared Oasheim - Chief Financial Officer Conference Call Participants Robbie Marcus - JPMorgan Matthew O'Brien - Piper Sandler Margaret Kaczor - William Blair William Plovanic - Canaccord Genuity Alex Nowak - Craig-Hallum Operator Good day and welcome to the CVRx Q4 2022 Earnings Conference Call. At this time, all p ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | |-------------------------------------------------------------------------|------------------------------------------------------------------------ ...

CVRx, Inc. (NASDAQ:CVRX) Q3 2022 Earnings Conference Call November 1, 2022 5:30 PM ET Company Participants Mike Vallie - Westwicke, ICR Company Nadim Yared - President and CEO Jared Oasheim - CFO Conference Call Participants Matthew O'Brien - Piper Sandler Margaret Kaczor - William Blair Bill Plovanic - Canaccord Alex Nowak - Craig-Hallum Operator Good day and thank you for standing by. Welcome to the CVRx Third Quarter 2022 Earnings Conference Call. [Operator Instructions]. Please be advised that today's c ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | |-----------------------------------------------|--------------------------------------------------------------------------------------|---------------- ...

CVRx, Inc. (NASDAQ:CVRX) Q2 2022 Earnings Conference Call July 28, 2022 5:30 PM ET Company Representatives Nadim Yared - President, Chief Executive Officer Jared Oasheim - Chief Financial Officer Mike Vallie - Westwicke, ICR Company Conference Call Participants Matthew O’Brien - Piper Sandal Margaret Kaczor - William Blair Alex Nowak - Craig-Hallum William Plovanic - Canaccord Operator Good day and thank you for standing by. Welcome to the CVRx Second Quarter 2022 Earnings Conference Call. [Operator Instruc ...